MIR3188
gene geneOn this page
Also known as hsa-mir-3188
Summary
MIR3188 (microRNA 3188, HGNC:38226) is a microRNA gene on chromosome 19p13.11.
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.
Source: NCBI Gene 100422833 — RefSeq curated summary.
At a glance
- Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:38226 |
| Approved symbol | MIR3188 |
| Name | microRNA 3188 |
| Location | 19p13.11 |
| Locus type | RNA, micro |
| Status | Approved |
| Aliases | hsa-mir-3188 |
| Ensembl gene | ENSG00000267959 |
| Ensembl biotype | miRNA |
| Entrez | 100422833 |
| RNAcentral | URS000075E5AE — miRNA, 85 nt, 5 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 miRNA
ENST00000583494
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000583494 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002718412 | 18282077 | 18282161 |
Expression profiles
Bgee: expression breadth broad, 96 present calls, max score 87.47.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.3428 / max 273.0051, expressed in 924 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 174638 | 5.3428 | 924 |
Top tissues by expression
96 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.47 | gold quality |
| vermiform appendix | UBERON:0001154 | 86.24 | gold quality |
| monocyte | CL:0000576 | 85.70 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 85.14 | gold quality |
| duodenum | UBERON:0002114 | 80.68 | gold quality |
| lymph node | UBERON:0000029 | 78.11 | gold quality |
| blood | UBERON:0000178 | 77.34 | gold quality |
| islet of Langerhans | UBERON:0000006 | 75.04 | gold quality |
| calcaneal tendon | UBERON:0003701 | 75.02 | gold quality |
| muscle of leg | UBERON:0001383 | 74.45 | gold quality |
| bone marrow | UBERON:0002371 | 74.32 | gold quality |
| liver | UBERON:0002107 | 73.65 | gold quality |
| adrenal tissue | UBERON:0018303 | 73.10 | gold quality |
| gastrocnemius | UBERON:0001388 | 73.09 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 73.09 | gold quality |
| left uterine tube | UBERON:0001303 | 71.35 | gold quality |
| endometrium | UBERON:0001295 | 70.79 | gold quality |
| body of pancreas | UBERON:0001150 | 70.70 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 70.51 | gold quality |
| placenta | UBERON:0001987 | 70.49 | gold quality |
| right lobe of liver | UBERON:0001114 | 69.96 | gold quality |
| urinary bladder | UBERON:0001255 | 69.55 | gold quality |
| stomach | UBERON:0000945 | 69.36 | gold quality |
| heart left ventricle | UBERON:0002084 | 69.07 | gold quality |
| body of stomach | UBERON:0001161 | 68.95 | gold quality |
| adrenal gland | UBERON:0002369 | 68.68 | gold quality |
| right atrium auricular region | UBERON:0006631 | 68.65 | gold quality |
| granulocyte | CL:0000094 | 68.61 | gold quality |
| heart | UBERON:0000948 | 68.39 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 68.26 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.47 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 8)
- miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN. (PMID:27095304)
- our study indicates that downregulation of miR-3188 may contribute to atherosclerosis development via negatively regulating Lp-PLA2, targeting ELK4 and activating the RhoA/ROCK pathway (PMID:29442044)
- Findings revealed that CAF-derived exosomes contain lower miR-3188 levels than NFs, and the loss of miR-3188 in exosomes contributes to the malignant phenotypes of HNC cells through the derepression of BCL2. (PMID:30961650)
- The miR-3188 (rs7247237-C>T) polymorphism is associated with the incidence of vascular complications in Chinese patients with type 2 diabetes. (PMID:31274844)
- miR-3188 Regulates proliferation and apoptosis of granulosa cells by targeting KCNA5 in the polycystic ovary syndrome. (PMID:33533580)
- The Interaction of Human and Epstein-Barr Virus miRNAs with Multiple Sclerosis Risk Loci. (PMID:33805769)
- MiR-3188 regulates the proliferation and apoptosis of hepatocellular carcinoma cells by targeting CXCL14. (PMID:34704819)
- miR-3188 inhibits hepatitis B virus transcription by targeting Bcl-2. (PMID:38565755)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.